Letter to the EditorSpread of mcr-1.5 in the community: an emerging threat
Section snippets
Acknowledgments
The authors thank the technical staff and directors in the 38 participating facilities in Japan. The authors also express their appreciation to Tse Hsien Koh (Singapore General Hospital, Singapore) and Jean B. Patel (US Centers for Disease Control and Prevention, Atlanta, GA) for critical reading and helpful suggestions.
Whole-genome sequence data deposition: Raw draft genome sequence reads of E. coli TUM17668 were deposited in the DDBJ Sequence Read Archive under accession no. BDSB01000001–
References (5)
- et al.
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
Lancet Infect Dis
(2016) - et al.
Investigation of a plasmid genome database for colistin-resistance gene mcr-1
Lancet Infect Dis
(2016)
Cited by (9)
Prevalence of colistin-resistant mcr-1-positive Escherichia coli isolated from children patients with diarrhoea in Shanghai, 2016–2021
2023, Journal of Global Antimicrobial ResistanceAvian-source mcr-1-positive Escherichia coli is phylogenetically diverse and shares virulence characteristics with E. coli causing human extra-intestinal infections
2019, Veterinary MicrobiologyCitation Excerpt :The mcr-1-carrying plasmid pE166-MCR1, belonging to IncI2 replicon, contained a conjugal transfer region, mcr-1 inserting elements, and β-lactamase blaCTX-M-64 resistance gene (Fig. 3B). pE166-MCR1 shared high identity with plasmid pMTY17668-MCR1.5 (62,375bp, NZ_AP018110.1) in an invasive E. coli from a Japanese infant(Ishii et al., 2018). The high-virulent MDR MCRPEC strain CT30 also harbored 3 large plasmids (Fig. 3C).
Non-prescription sales of antimicrobial agents at community pharmacies in developing countries: a systematic review
2018, International Journal of Antimicrobial AgentsCitation Excerpt :The emergence of antimicrobial-resistant micro-organisms presents considerable challenges for human health [1]. Resistant microbes have the potential to rapidly and easily spread across and between continents [2], hence antimicrobial resistance (AMR) is not limited to one country or one continent [3] but is a global public-health problem [4]. The impact of AMR will have greater deleterious effects on the health of inhabitants in poorer and developing nations compared with developed countries because infectious diseases represent a major burden in these countries with dense populations, poor sanitation, malnutrition, developing health systems, and low income with poor health facilities [5].
Isolation of a mcr-1-harbouring Escherichia coli isolate from a human clinical setting in Sapporo, Japan
2018, Journal of Global Antimicrobial ResistanceColistin Resistance in Aquaculture Environment: An Emerging Challenge
2023, Macromolecular Symposia
- 1
These two authors contributed equally to this work.